drugset / Trial / NCT04221906
Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is being conducted to evaluate the safety of topical BOS-475 compared to topically applied comparator formulations and vehicle.
Timeline
- Start
- 2020-01-06
- Primary completion
- 2020-03-06
- Completion
- 2020-03-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BOS-475 | Unknown | 0.5 % | Topical |
| Subject | BOS-475 | Unknown | 1 % | Topical |
| Subject | BOS-475 | Unknown | 2 % | Topical |
| Comparator | Betamethasone | Other / unclassified | 0.1 % | Topical |
| Comparator | Calcipotriol | Small molecule | 0.005 % | Topical |